October 2020 Journal Club

Tuesday, October 13, 2 pm CDT

Tammy Li, PharmD presents Olaparib for Metastatic Castration-Resistant Prostate Cancer
Sarah Tu, PharmD presents Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Joe Kalis, PharmD was the moderator.

A recording of the live webinar is available in this course and will remain active for one year.

Please take the post-webinar survey to give feedback on the webinar using this link: https://www.hoparx.org/apps/october-2020-journal-club-evaluation/


Tammy Li, PharmD
PGY-2 Oncology Pharmacy Resident
Allegheny General Hospital

Sarah Tu, PharmD 
PGY-2 Oncology Pharmacy Resident
M Health Fairview/University of Minnesota

Joe Kalis, PharmD
Ambulatory Oncology Clinical Specialist

This was a live webinar open to members and non-members. No credit is given for this education. If you have questions about Journal Club, please contact HOPA Education at education@hoparx.org